GlaxoSmithKline News

Amid reports of a US Congress probe against India's largest drug maker Ranbaxy Laboratories, data show that many leading multinational companies such as Pfizer, GlaxoSmithKline, Novartis and Merck are also ...

Genentech reported yesterday that its first-quarter overall revenue rose nearly 8%. Its top drugs, including cancer treatments Avastin and Rituxan, posted blowout double-digit sales growth.

Main Category: Respiratory / Asthma Also Included In: Clinical Trials / Drug Trials Article Date: 15 Jul 2008 Theravance, Inc.

British pharmaceutical giant GlaxoSmithKline is to pay up to 1.2 billion for the rights to develop and sell almorexant, an anti-insomnia treatment in its final testing.

The UK's largest drug company, GlaxoSmithKline, is to pay up to SFr3.3bn in licensing and development fees for insomnia treatment Almorexant.

Europe's biggest drugmaker GlaxoSmithKline could pay up to 3.3 billion Swiss francs for a licensing deal on a promising insomnia drug from Swiss company Actelion .

It was a good play. When Pfizer 's epilepsy drug Lyrica was included in a list of 11 drugs that might need a black-box warning, company executives said it wasn't so.

Main Category: Cervical Cancer / HPV Vaccine Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials GlaxoSmithKline provided the following update regarding its application to the ...

TUMS, one of the most trusted brands for indigestion and heartburn relief, is launching a nationwide search for one lucky fan to serve as the Grand Marshal of the TUMS QuikPak 500 Sprint Cup Series race at ...

July 8, 2008 -- GlaxoSmithKline Plc said it will increase its China-based research and development staff to 350 people in the next few years.

The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials Adolor Corporation today issued an update on the Entereg Program for chronic opioid bowel dysfunction , under ...

Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than $114 million for overcharging the state's Medicaid program for prescription drugs.

Main Category: Cervical Cancer / HPV Vaccine Also Included In: Regulatory Affairs / Drug Approvals Article Date: 03 Jul 2008 GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its ...

GuruFocus Home >> Stock Ideas >> Recent Picks >> Glaxosmithkline Plc GSK - GlaxoSmithKline plc $117.2 Bil 18.69% 52.22% 6.3 33.19% 2.58 23.01% 4.94% $0 2664.26 Mil GlaxoSmithKline is one of the world's leading ...

Drug companies GlaxoSmithKline and Novartis say they will appeal a jury verdict ordering them to pay more than $114 million to Alavbama for overcharging the state's Medicaid program for prescription drugs.

Main Category: Diabetes Also Included In: Cardiovascular / Cardiology Article Date: 03 Jul 2008 - 13:00 PDT Sirtris, a GlaxoSmithKline company focused on discovering and developing small molecule drugs to treat ...

Main Category: Medicare / Medicaid / SCHIP Also Included In: Pharma Industry / Biotech Industry ; Medical Malpractice / Litigation Article Date: 03 Jul 2008 - 6:00 PDT An Alabama state court jury on Tuesday ...

Jul 3, 2008 - Adolor Corporation today issued an update on the Entereg Program for chronic opioid bowel dysfunction , under development in collaboration with GlaxoSmithKline .

By MATTHEW PERRONE The Associated Press Wednesday, July 2, 2008; 4:31 PM WASHINGTON -- Diabetes drugs would be subject to more stringent safety standards that could cost manufacturers millions, under ...